spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Precision Therapeutics 

 HSMN NewsFeed - 31 Aug 2026
Lilly to Acquire Merida Biosciences to Advance Treatments for Serious Autoimmune and Allergic Diseases
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Jun 2025
Neurvati Neurosciences and GRIN Therapeutics Announce Appointment of Gail Farfel, PhD to Their Boards of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 4 Apr 2024
Caris Life Sciences Announces Partnership with Merck KGaA, Darmstadt, Germany to Discover Novel Cancer Targets and Accelerate First-In-Class Antibody Drug Conjugate Development
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Dec 2023
Hummingbird Bioscience Strengthens Leadership Team with Appointment of Angèle Maki as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2023
Mantra Bio Raises $9 Million in Series A-2 Financing to Advance Development of Lead Targeted Exosome Therapeutics Program
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 29 Nov 2021
Blueprint Medicines to Expand Precision Therapy Leadership in Lung Cancer with Acquisition of Lengo Therapeutics
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 5 Feb 2021
Jubilant Therapeutics Appoints Dr. Robert Glassman to its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Nov 2020
Elevation Oncology Announces $65M Series B Financing and Promotion of Founder Shawn M. Leland to Chief Executive Officer
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 2 Nov 2020
Athos Therapeutics Announces Appointment of Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Sep 2018
Dr. Dmitry Samarsky Joins Sirnaomics Senior Management Team as Chief Technology Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Mar 2018
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray, LLC
Biopharmaceuticals Personalized Medicine Licensing
 HSMN NewsFeed - 20 Feb 2018
Merrimack Announces Formation of New Scientific Advisory Board with Extensive Expertise in Precision Oncology
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 Sep 2016
Helix Twelve Pharmaceuticals Appoints Fred R. Seddiqui as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Feb 2016
LAM Therapeutics Closes $40M in Financing and Announces Two Clinical-Stage Programs in Rare Diseases and Cancer
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 18 Feb 2015
Biodesix Builds on Investments in Sales, Reimbursement and Government Affairs Growth Strategy
Diagnostics Personnel
 HSMN NewsFeed - 11 Mar 2013
Precision Therapeutics Announces Topline Prospective Clinical Data Demonstrating Significant Improvement in Overall Survival and Progression Free Survival in Recurrent Ovarian Cancer using Personalized Chemotherapy Diagnostic ChemoFx(R)
Diagnostics Oncology Personalized Medicine
 HSMN NewsFeed - 24 Jan 2012
Precision Therapeutics Enhances Their Straightforward Approach to Personalizing Cancer Care
Diagnostics Oncology Personalized Medicine
 HSMN NewsFeed - 19 Jan 2011
Precision Therapeutics Announces Two Pancreatic Cancer Studies Emphasizing the Utility of ChemoFx(R) in Cancer Treatment Options
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 21 Sep 2010
Susan Hertzberg Named CEO of Boston Heart Lab; Company Closes $10 Million in Series C Financing with Bain Capital Ventures as Lead Investor
Diagnostics Personnel Venture Capital
 HSMN NewsFeed - 14 Jan 2010
BIND Biosciences, Inc. closes $11 M Series C financing round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Dec 2009
Access Pharmaceuticals Appoints Sales and Marketing Executive
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Jul 2009
Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jun 2009
Laboratory Test May Predict Effectiveness of ERBITUX(R) for Individual Colorectal Cancer Patients
Diagnostics Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Apr 2009
Molecular Diagnostics Company, RedPath, Appoints Mark D. Myslinski as Chief Executive Officer
Diagnostics Personnel
 HSMN NewsFeed - 10 Nov 2008
Precision Therapeutics Secures $43 Million in Venture Capital Funding
Diagnostics Venture Capital
 HSMN NewsFeed - 4 Dec 2007
Oracle Healthcare Acquisition Corp. and Precision Therapeutics Announce Definitive Merger Agreement
Biopharmaceuticals Oncology Mergers & Acquisitions
Return to NewsFeed  

 Additional items found! 2

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 2 additional stories matching:
Precision Therapeutics
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!